
CN Bio raises $21 million USD in first close of Series B investment round
Summarize this content to 100 words Bayland Capital and founding shareholder, CN Innovations Holdings Ltd, to invest $10 M and $5.5 M, respectively. Investment will expand product development and scaling of the organization to meet increased demand for Organ-on-a-Chip (OOC) solutions. Image Credit: CN Bio CN Bio, a leading provider of single- and multi-organ microphysiological…